Glycans in Diseases and Therapeutics
Glycomedicine plays major role in cell-cell adhesion i.e. a method used by cells of the immune system via sugar-binding proteins called lectins, which identifies specific carbohydrate moieties. Glycan’s (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play major roles in many biological phenomena as well as in various pathophysiological processes. Many scientists in other fields of research have now realized that glycosylation, i.e. the addition of glycans to a protein backbone, is the most abundant post translational modification reactions and is an important field of research and sometimes they require a glycobiology and/or glycochemistry approach to be used.
- Congenital disorders of glycosylation (CDG)
- Cardiovascular diseases
- Cancer biomarkers
- Cancer associated coagulopathies
- Transfusion medicine
- Cardiac arrest
- Glycomedicine
Related Conference of Glycans in Diseases and Therapeutics
Glycans in Diseases and Therapeutics Conference Speakers
Recommended Sessions
- Glycoconjugates, Glycomics and Transcriptomics
- Glycoimmunology
- Genomics and Metabolomics
- Glycan’s in Vaccine Development
- Glycans in Diseases and Therapeutics
- Glycans in Structural and Computational Systems Biology
- Glycobiology and Glycochemistry
- Glycobiology in Lipid Science
- Glycochemistry
- Glycoinformatics
- Glyconeurobiology: Glycans in Neuroscience
- Glycopathology: Glycans in Cancer
- Glycosciences and Monosaccharides
- Glycosides
- Mass Spectrometry Analysis
- Structural Bioinformatics and Proteomics